treats Platelet aggregation inhibition, Reactivity/brain activity, Intermittent claudication, High cholesterol, and Coronary Heart Disease
This information is based on a systematic review of scientific literature, and was peer- reviewed and edited by contributors to the Natural Standard Research Collaboration (www.naturalstandard.com): Tracee Rae Abrams, PharmD (University of Rhode Island); Ethan Basch, MD (Memorial Sloan- Kettering Cancer Center); Julie Conquer, PhD (RGB Consulting); Nicole Giese, MS (Boston University); Dana Hackman, BS (Northeastern University); Ben Kligler, MD, MPH; Tamara Milkin, PharmD (Northeastern University); Erica Seamon, PharmD (Nova Southeastern University); Shaina Tanguay- Colucci, BS (Natural Standard Research Collaboration); Catherine Ulbricht, PharmD (Massachusetts General Hospital); Wendy Weissner, BA (Natural Standard Research Collaboration); Jen Woods, BS (Natural Standard Research Collaboration).
BibliographyDISCLAIMER: Natural Standard developed the above evidence- based information based on a thorough systematic review of the available scientific articles. For comprehensive information about alternative and complementary therapies on the professional level, go to www.naturalstandard.com. Selected references are listed below.
Bays H, Stein EA. Pharmacotherapy for dyslipidaemia- - current therapies and future agents. Expert Opin Pharmacother 2003;4(11):1901- 1938.
Berthold HK, Unverdorben S, Degenhardt R, et al. Effect of policosanol on lipid levels among patients with hypercholesterolemia or combined hyperlipidemia: a randomized controlled trial. JAMA 2006 May 17;295(19):2262- 9.
Castaño G, Más R, Fernández L, et al. A comparison of the effects of D- 003 and policosanol (5 and 10 mg/ day) in patients with type II hypercholesterolemia: a randomized, double- blinded study. Drugs Exp Clin Res 2005;31 Suppl:31- 44.
Chen JT, Wesley R, Shamburek RD, et al. Meta- analysis of natural therapies for hyperlipidemia: plant sterols and stanols versus policosanol. Pharmacotherapy 2005;25(2):171- 183.
Cubeddu LX, Cubeddu RJ, Heimowitz T, et al. Comparative lipid- lowering effects of policosanol and atorvastatin: a randomized, parallel, double- blind, placebo- controlled trial. Am Heart J 2006 Nov;152(5):982.e1- 5.
Dulin MF, Hatcher LF, Sasser HC, et al. Policosanol is ineffective in the treatment of hypercholesterolemia: a randomized controlled trial. Am J Clin Nutr 2006 Dec;84(6):1543- 8.
Francini- Pesenti F, Beltramolli D, Dall'acqua S, Brocadello F. Effect of sugar cane policosanol on lipid profile in primary hypercholesterolemia. Phytother Res. 2008 Mar;22(3):318- 22.
Gamez R, Maz R, Arruzazabala ML, et al. Effects of concurrent therapy with policosanol and omega- 3 fatty acids on lipid profile and platelet aggregation in rabbits. Drugs R D 2005;6(1):11- 19.
Greyling A, De Witt C, Oosthuizen W, et al. Effects of a policosanol supplement on serum lipid concentrations in hypercholesterolaemic and heterozygous familial hypercholesterolaemic subjects. Br J Nutr 2006 May;95(5):968- 75.
Illnait J, Castaño G, Alvarez E, Fernández L, Mas R, Mendoza S, Gamez R. Effects of policosanol (10 mg/ d) versus aspirin (100 mg/ d) in patients with intermittent claudication: a 10- week, randomized, comparative study. Angiology. 2008 Jun- Jul;59(3):269- 77.
Kassis AN, Jones PJ. Changes in cholesterol kinetics following sugar cane policosanol supplementation: a randomized control trial. Lipids Health Dis. 2008 Apr 30;7:17.
Mas R, Castano G, Fernandez J, et al. Long- term effects of policosanol on obese patients with Type II Hypercholesterolemia. Asia Pac J Clin Nutr 2004;13(Suppl):S102.
McCarty MF. An ezetimibe- policosanol combination has the potential to be an OTC agent that could dramatically lower LDL cholesterol without side effects. Med Hypotheses 2005;64(3):636- 645.
Reiner Z, Tedeschi- Reiner E. Rice policosanol does not have any effects on blood coagulation factors in hypercholesterolemic patients. Coll Antropol. 2007 Dec;31(4):1061- 4.
Tedeschi- Reiner E, Reiner Z, Romić Z, et al. [A randomized, double- blind, placebo- controlled study of the antilipemic efficacy and tolerability of food supplement policosanol in patients with moderate hypercholesterolemia]. Lijec Vjesn 2005 Nov- Dec;127(11- 12):273- 9.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.